The HCTB Core will assist PJIs with the application of their promising research to the field of clinical viral oncology through prioritization of clinical data and biospecimen collection for PJIs in the Center for Translational Viral Oncology (CTVO). The CTVO will support personnel in the Core who will provide services to the PJIs at no cost. This unique HIV/Clinical Tumor Biorepository (HCTB) organized and directed by Dr. Parsons collects biospecimens from the HIV/AIDS Malignancy Program and from other oncology clinics that evaluate, diagnose and treat patients with viral associated malignancies. These patients have a disproportionate representation of minorities, mostly African American. Our overarching goal is to assist PJIs with performance of high-quality translational research utilizing linked biospecimens and clinical data from patients receiving care at the University Medical Center ? New Orleans - Infectious Diseases Center (UMCNO- IDC) and its affiliated partners (HIV/AIDS Malignancy Program and others). Use of these samples will inform and ensure clinical relevance for their mechanistic studies and promote clinical translation of their work. Through this effort, we seek in the future to improve health outcomes for underserved HIV+ patients at risk for virus-associated cancers. In addition access to these unique samples should provide successful PJI's with a competitive edge as they apply for independent grant funding. The HCTB Core will support the translational research proposed by PJIs in the CTVO through the following Specific Aims: 1) To assist PJIs with IRB applications and design of translational studies; 2) To expand an integrated, clinic-based system for collection of linked clinical data and biospecimens from HIV+ patients in New Orleans who are at high risk for virus- associated cancers; 3) To ensure storage of high-quality HIV+ biospecimens for easy access by PJIs; and 4) To perform timely shipment of HIV+ biospecimens to external collaborators for PJIs.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Louisiana State Univ Hsc New Orleans
New Orleans
United States
Zip Code
Lassak, Adam; Dean, Mathew; Wyczechowska, Dorota et al. (2018) Molecular and Structural Traits of Insulin Receptor Substrate 1/LC3 Nuclear Structures and Their Role in Autophagy Control and Tumor Cell Survival. Mol Cell Biol 38:
Qiao, Jing; Cao, Yueyu; Zabaleta, Jovanny et al. (2018) Regulation of Virus-Associated Lymphoma Growth and Gene Expression by Bacterial Quorum-Sensing Molecules. J Virol 92:
Dai, Lu; Del Valle, Luis; Miley, Wendell et al. (2018) Transactivation of human endogenous retrovirus K (HERV-K) by KSHV promotes Kaposi's sarcoma development. Oncogene 37:4534-4545
Dai, Lu; Smith, Charles D; Foroozesh, Maryam et al. (2018) The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo. Int J Cancer 142:2153-2162
Dai, Lu; Qiao, Jing; Del Valle, Luis et al. (2018) KSHV co-infection regulates HPV16+ cervical cancer cells pathogenesis in vitro and in vivo. Am J Cancer Res 8:708-714
Lin, Zhen; Nguyen, Christian; Xu, Beibei et al. (2018) Interleukin-17A in the Pathogenesis of Lung Adenocarcinoma. Ann Am Thorac Soc 15:S125
Ungerleider, Nathan; Concha, Monica; Lin, Zhen et al. (2018) The Epstein Barr virus circRNAome. PLoS Pathog 14:e1007206
Dai, Lu; Zhao, Mengmeng; Jiang, Wei et al. (2018) KSHV co-infection, a new co-factor for HPV-related cervical carcinogenesis? Am J Cancer Res 8:2176-2184
Mills, Kylie L; Gomes, Angelica M; Standlee, Courtney R et al. (2018) Gas6 is dispensable for pubertal mammary gland development. PLoS One 13:e0208550
Dai, Lu; Lin, Zhen; Jiang, Wei et al. (2017) Lipids, lipid metabolism and Kaposi's sarcoma-associated herpesvirus pathogenesis. Virol Sin 32:369-375

Showing the most recent 10 out of 13 publications